Primary |
Colonoscopy |
25.0% |
Drug Use For Unknown Indication |
25.0% |
Bowel Preparation |
16.7% |
Hypertension |
12.5% |
Product Used For Unknown Indication |
12.5% |
Constipation |
8.3% |
|
Renal Failure Chronic |
19.0% |
Vomiting |
14.3% |
Syncope |
9.5% |
Contraindication To Medical Treatment |
4.8% |
Hypocalcaemia |
4.8% |
Hypomagnesaemia |
4.8% |
Intracardiac Thrombus |
4.8% |
Paraesthesia Oral |
4.8% |
Peritonitis |
4.8% |
Renal Disorder |
4.8% |
Renal Failure Acute |
4.8% |
Renal Impairment |
4.8% |
Somnolence |
4.8% |
Toxicity To Various Agents |
4.8% |
Urinary Tract Infection |
4.8% |
|
Secondary |
Parenteral Nutrition |
54.2% |
Constipation |
16.7% |
Colonoscopy |
4.2% |
Diabetes Mellitus |
4.2% |
Major Depression |
4.2% |
Oedema Peripheral |
4.2% |
Pain |
4.2% |
Type 2 Diabetes Mellitus |
4.2% |
Vomiting |
4.2% |
|
Renal Failure Acute |
50.0% |
Urinary Retention |
25.0% |
Weight Decreased |
25.0% |
|
Concomitant |
Product Used For Unknown Indication |
36.7% |
Adverse Event |
16.5% |
Drug Use For Unknown Indication |
15.2% |
Pain |
5.6% |
Prophylaxis |
3.7% |
Acute Myeloid Leukaemia |
2.6% |
Constipation |
2.5% |
Nausea |
2.3% |
Mantle Cell Lymphoma |
1.7% |
Premedication |
1.5% |
Breakthrough Pain |
1.4% |
Hypertension |
1.4% |
Prostate Cancer |
1.3% |
Vomiting |
1.3% |
Neoplasm Malignant |
1.2% |
Supplementation Therapy |
1.2% |
Depression |
1.1% |
Thrombosis Prophylaxis |
1.1% |
Vitamin Supplementation |
0.9% |
Acute Lymphocytic Leukaemia |
0.8% |
|
Pneumonia |
11.4% |
Cardiac Arrest |
10.0% |
Vomiting |
10.0% |
Ventricular Tachycardia |
7.1% |
Dehydration |
5.7% |
Grand Mal Convulsion |
5.7% |
Febrile Neutropenia |
4.3% |
Pyrexia |
4.3% |
Renal Failure |
4.3% |
Sepsis |
4.3% |
Septic Shock |
4.3% |
Weight Increased |
4.3% |
White Blood Cell Count Increased |
4.3% |
Failure To Thrive |
2.9% |
Haemoglobin Decreased |
2.9% |
Hypotension |
2.9% |
Intestinal Obstruction |
2.9% |
Necrotising Colitis |
2.9% |
Neutropenic Colitis |
2.9% |
Pain In Extremity |
2.9% |
|
Interacting |
Product Used For Unknown Indication |
85.7% |
Colonoscopy |
14.3% |
|
Renal Failure Acute |
100.0% |
|